Nandazurine is primarily used in the research and development of pharmaceutical agents targeting central nervous system disorders. It serves as a key intermediate in synthesizing compounds with potential anxiolytic and anticonvulsant properties. Due to its ability to modulate specific neurotransmitter receptors, it is investigated for use in treating anxiety, epilepsy, and related neurological conditions. Its structural characteristics make it valuable in creating novel derivatives for preclinical screening. Nandazurine is not intended for direct therapeutic use but plays a significant role in medicinal chemistry for optimizing drug candidates with improved efficacy and safety profiles.